Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

No items found.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

The study is ongoing at this time.